
overall trend of the market. One such stock is Prestige Brands ( PBH ) which sells basic products that should hold up well in a slow ..... Efferdent denture products. Key announcements and catalysts for PBH : It beat earnings estimates this week with adjusted earnings
Prestige Brands ( PBH +1.5% ) is higher today after Oppenheimer upgraded the stock to Outperform with a $17 price target. The firm believes the
May 17 (Reuters) - Prestige Brands Holdings Inc posted an adjusted quarterly profit that beat analysts' expectations, helped by higher sales of its over-the-counter brands.
Prestige Brand ( PBH ): FQ4 EPS of $0.26 beats by $0.03 . Revenue of $134M (+39% Y/Y) in-line. ( PR ) Post your comment!
Shares of Prestige Brands ( PBH -14.5% ) are trading lower after Genomma Lab ..... products maker. Genoma says that despite satifying PBH 's conditions in its original buyout proposal, the PBH unreasonably refused to continue discussions without
MEXICO CITY, May 3 (Reuters) - Mexican pharmaceutical products company Genomma Lab said on Thursday it will drop its offer for Prestige Brands Holdings , after that company rejected the offer.
April 26 (Reuters) - Mexican pharmaceutical products company Genomma Lab said on Thursday its board will not raise its initial $16.60 per share offer for Prestige Brands Holdings , in spite of that company rejecting the offer.
MEXICO CITY, March 15 (Reuters) - Prestige Brands Holdings Inc, maker of Comet and Spic and Span cleaners, criticized Mexican company Genomma's bid to nominate five people to Prestige's board and again rejected that company's acquisition offer.
Prestige Brands ( PBH +2% ) rejects Genomma Lab's $834M unsolicited bid to acquire the maker of Comet and Spic n Span cleaners, calling it "inadequate." PBH adopts a shareholder rights plan in response to the bid, saying it would
March 12 (Reuters) - Prestige Brands Holdings Inc , the maker of Comet and Spic and Span cleaners, rejected Genomma Lab's $834 million unsolicited bid to acquire the company, calling it "inadequate."